Skip to content

Public FDA record

Z-2497-2018: RayStation stand-alone software treatment planning system, RayStation 4.5, RayStation 4.7, RayStation 4.

Recall record Z-2497-2018 for RAYSEARCH LABORATORIES AB. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2497-2018
Company in FDA record
RAYSEARCH LABORATORIES AB
FDA record creation date
Jul 19, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

If the beam model has a highly asymmetric primary source, it is not correctly taken into account in the calculation of DMLC fields when the collimator is rotated. This could lead to potentially significant overdosage at delivery. The user must be aware of the issue to avoid incorrect dose calculations during treatment planning.

Source facts

Action
On June 29, 2018, the firm issued an Urgent Field Safety Notice, Medical Device Correction #32484 to affected customers via email. The firm notified customers of the issue with the affected models: If the beam model has a highly asymmetric primary source, it is not correctly taken into account in the calculation of DMLC fields when the collimator is rotated. The user was instructed to do the following: 1. Inspect the beam model for all LINACs with jaw movement per beam, x-jaws and where the MLC is not above both jaws (i.e., Varian style LINACs) that allow DMLC planning. 2. If either the x- or y width of the primary source is below 0.01 cm or if they differ with more than a factor 2, do not use this beam model for DMLC. Contact RaySearch support for further assistance in adjusting the beam model and identifying potentially affected patients. 3. Please educate physics staff about this issue. 4. Inspect your product and identify all installed units with the above software version number(s), then confirm that you have read and understood this notice by replying to the notification email. The firm plans to resolve the issue in the next version of RayStation/RayPlan, scheduled for market release in 2018 (subject to market clearance in some markets).
Initiated
2018-06-29
Root cause
Under Investigation by firm
Terminated
2020-07-16
Distribution
US Nationwide Distribution to accounts in AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, LA, MA, MD, ME, MI, MO, MS, MT, NC, NJ, NV, NY, OH, OK, OR, PA, RI, TN, TX, UT, VA, VT, WA, and WI.
Recall number
Z-2497-2018
Recall status
Terminated
CDRH record ID
165527
FDA record created
2018-07-19
Recall event number
80459

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗